Geron Corporation | Company Profile
11/18/2025
Contact Information
👤
Geron Corporation
🏢
Geron Corporation
📍
919 E Hillsdale Blvd, Foster City, California 94404, US
Industry & Market
Primary Industry
research
Location
Foster City, California, United States
Public Trading
NASDAQ: GERN
Company Metrics
👥Total Employees
97
⚙️Engineering
2
💼Sales Team
3
📈Marketing
7
📅Founded
1992
💰Revenue
77.0M
Funding Information
Market Cap
$682.7M
Annual Revenue
$76,994,000
Publicly traded company
Headcount Distribution
Total Employees
97
Departments
19
By Department
Department Breakdown
Operations
Business Development
Human Resources
Legal
Finance
Information Technology
Others
Technology Stack
Analytics & Tracking
Google Tag Manager
Email & Communication
Outlook
Total: 11 technologies
Keywords & Focus Areas
oncologyhematologic malignanciestelomerase inhibitionbiotechnology: pharmaceutical preparationshealth carebiotechnology researchbiotechnologyhematologic cancer treatmentscancer researchblood cancer innovationcancer stem cellsbiotech manufacturingtelomerase rna inhibitioncancer immunotherapyclinical developmentcancer diagnosticsresearch and development in the physical, engineering, and life sciencesoncology marketblood cancer drug developmentblood malignancy therapies+10 more
30 total keywords
Geron Corporation
Overview
Geron Corporation is a biotechnology company based in Foster City, California. The organization specializes in developing and commercializing therapeutic products to treat blood cancers, particularly hematologic malignancies, with a focus on telomerase inhibition—a distinct strategy targeting a key enzyme active in many forms of cancer.
The company’s flagship product, RYTELO (imetelstat), is approved for adult patients with low- to intermediate-1 risk myelodysplastic syndromes who are transfusion-dependent. Geron is committed to advancing innovative therapies that improve and extend the lives of individuals battling blood cancers. Its core mission is to drive scientific excellence and patient-centric innovation in oncology therapeutics.
Basic Information
| Industry | research |
|---|---|
| Founded | 1992 |
| Revenue | $77.0M |
| Headquarters | 919 E Hillsdale Blvd, Foster City, California 94404-2112, United States |
| Languages | English |
Contact Details
- Phone: +1 650-473-7700
- Website: geron.com
- LinkedIn: linkedin.com/company/geron
Key Focus Areas & Initiatives
- Oncology
- Telomerase inhibition
- Blood cancer research
- Therapeutic product development
- Cancer cell biology and targeting
- Imetelstat & telomerase inhibitor therapies
- Biopharmaceutical innovation
- Research in hematologic malignancies
- Targeted cancer therapies
- Clinical development and regulatory approval
Technologies Used
- AI
- BugHerd
- DNS Made Easy
- Google Font API
- Google Tag Manager
- Microsoft Office 365
- Mimecast
- Mobile Friendly
- Outlook
- Remote
- WordPress.org
Community
